Pharmaceutical

Implementation of MDG-BP

About the customer

With approximately 51,000 employees worldwide, our customer is the largest research-driven pharmaceutical company in Germany. Its core business includes the research, development, manufacture, and marketing of pharmaceuticals for humans and animals.

The challenges

Implementation of SAP MDG-BP for customer and supplier master data on one central MDG hub as part of a comprehensive master data road map.

The solution (highlights)

Concept and implementation of MDG-BP – adapted to the customer’s specific requirements:

Automatic linking of partner functions when creating a new business partner – in contrast to the standard system, partner functions can be used by automatically linking additional MDG change requests (CRs) to the existing main account
Checking of active SEPA mandate – this is not maintained in MDG, but in a third-party system. To keep bank-related customer data consistent, a check is carried out whenever bank data is changed or deleted to determine whether an active SEPA mandate in the third-party system is affected by this change
Enhancement of audit trail reporting for regulatory compliance – for example, IDMP reporting

The results

Less time and money spent on maintenance processes and data maintenance for enterprise master data – reduced data management costs
Higher level of business process automation supported by the standardization of master data – prevention of consequential errors and financial losses in the value chain
Provision of consistent and current data for more effective decision-making
Stronger compliance with regulatory requirements – reduced probability of security breaches and non-compliance with regulations